Healthways (Nasdaq: HWAY) filed its 10-K on Wednesday. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Healthways met expectations on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue dropped, and GAAP earnings per share shrank to a loss.

Margins dropped across the board.

Revenue details
Healthways reported revenue of $180 million. The nine analysts polled by S&P Capital IQ anticipated net sales of $181.5 million on the same basis. GAAP reported sales were 7.8% lower than the prior-year quarter's $195.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.27. The nine earnings estimates compiled by S&P Capital IQ forecast $0.33 per share on the same basis. GAAP EPS were -$5.32 for Q4 compared to $0.45 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 26%, 1,090 basis points worse than the prior-year quarter. Operating margin was 10.6%, 970 basis points worse than the prior-year quarter. Net margin was -98.4%, 10,640 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $155.9 million. On the bottom line, the average EPS estimate is $0.00.

Next year's average estimate for revenue is $674.4 million. The average EPS estimate is $0.46.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 394 members rating the stock outperform and 24 members rating it underperform. Among 152 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 145 give Healthways a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Healthways is hold, with an average price target of $8.50.

Over the decades, small-cap stocks, like Healthways have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.